Juvenile Idiopathic Arthritis
📧 Sign up to get email alerts when something new happens for Juvenile Idiopathic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-25Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis [Phase 1]
A Phase 1 trial evaluating pharmacokinetics and pharmacodynamics of biologic drugs in obese patients with arthritis has been withdrawn, with…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients
An ongoing clinical trial at Hacettepe University investigates how parental catastrophizing of their child's pain relates to juvenile idiopa…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Cognitive Exercise Therapy Approach (BETY) in JIA [NA]
A completed clinical trial evaluating the BETY cognitive exercise therapy approach for Juvenile Idiopathic Arthritis.
-
FDA approval · 2025-09-17FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
The FDA approved a supplemental BLA for AMJEVITA (adalimumab-atto) submitted by Nuvaila Limited. The action concerns regulatory approval rel…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Efficiency of Supervised Exercise Program Versus Mobile-Based Exercise Program in Juvenile Idiopathic Arthritis [NA]
A completed clinical trial comparing the efficiency of a supervised exercise program versus a mobile-based exercise program in Juvenile Idio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
A clinical trial update notes that recruitment is ongoing for a study on angiogenic biomarkers in Juvenile Idiopathic Arthritis. The study i…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating adalimumab for uveitis in juvenile idiopathic arthritis has completed.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
A recruiting clinical trial in France aims to develop a diagnosis, prognosis, and therapeutic decision-support tool for autoimmune and infla…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Fitness Integrative Training for Pediatric Rheumatology Disorders [NA]
The trial update reports completion of a study evaluating fitness integrative training for pediatric rheumatology disorders. The study inclu…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders [Phase 2]
This Phase 2 trial evaluating a COVID-19 booster vaccine in autoimmune-disease non-responders was terminated, with results posted on 2025-08…
-
EMA approval · 2025-08-13EMA Authorised: Enbrel (etanercept) — Pfizer Europe MA EEIG
The European Medicines Agency authorised Enbrel (etanercept) for multiple inflammatory diseases including rheumatoid arthritis, ankylosing s…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis [Phase 1]
This Phase 1 clinical trial assesses the pharmacokinetics, safety, and tolerability of Upadacitinib in pediatric patients with polyarticular…
-
FDA approval · 2025-07-29FDA Approved: ADALIMUMAB — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Sandoz Inc for the adalimumab biosimilar ADALIMUMAB-ADAZ, enabling its use with indications cons…
-
FDA approval · 2025-07-29FDA Approved: VYSCOXA — Original Application (Carwin Pharmaceutical Associates, LLC)
FDA approved VYSCOXA, a brand name for celecoxib, under Carwin Pharmaceutical Associates, LLC's original application. This confirms marketin…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Assessment of Composite Inflammatory Ratios in Juvenile Idiopathic Arthritis and Their Association With Disease Activity
This clinical trial aims to evaluate composite inflammatory ratios in Juvenile Idiopathic Arthritis and their relationship to disease activi…
-
EMA approval · 2025-07-17EMA Authorised: Nordimet (methotrexate) — Nordic Group B.V.
EMA authorised Nordimet (methotrexate) by Nordic Group B.V. for use in arthritis-related conditions including rheumatoid arthritis, psoriati…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
A clinical trial led by Oregon Health and Science University is evaluating methods to quantify and classify inflammatory cells in uveitis us…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis [NA]
A clinical trial evaluated ondansetron as a premedication for Juvenile Idiopathic Arthritis and it is reported as completed.
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: CAPRI National Juvenile Idiopathic Arthritis Registry
The CAPRI National Juvenile Idiopathic Arthritis Registry is currently recruiting to collect data on juvenile idiopathic arthritis.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: M3-JIA: Making Mindfulness Matter for Children With JIA [NA]
This is an update on the M3-JIA trial studying mindfulness for children with Juvenile Idiopathic Arthritis; the study is currently RECRUITIN…
-
FDA approval · 2025-06-05FDA Approved: XIFYRM — Original Application (Azurity Pharmaceuticals, Inc.)
FDA approved XIFYRM (meloxicam) under an original application by Azurity Pharmaceuticals, Inc., establishing a new branded meloxicam product…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Assessment of Cardiorespiratory Fitness Using the PACER in Patients With Juvenile Idiopathic Arthritis and Familial Mediterranean Fever
A completed clinical trial assessing cardiorespiratory fitness using the PACER test in youths with Juvenile Idiopathic Arthritis and Familia…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA [Phase 3]
Phase 3 safety, efficacy, and pharmacokinetics study of tofacitinib in pediatric patients with systemic juvenile idiopathic arthritis has co…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
This clinical trial update notes ongoing recruitment for a longitudinal follow-up study of newly diagnosed polyarthritis in children and you…
-
EMA approval · 2025-05-19EMA Authorised: Orencia (abatacept) — Bristol-Myers Squibb Pharma EEIG
The EMA authorised Orencia (abatacept) by Bristol-Myers Squibb Pharma EEIG for rheumatoid arthritis, psoriatic arthritis, and juvenile idiop…